Other relevant cancer targets, such as translational elongation and initiation factors (e.g., EIF4E), membrane receptors (e.g., EGFR), as well as RNA binding proteins, also showed a tendency towards better recovery, albeit not statistically significant. The gene discussed is EIF4E; the disease is cancer.